ROY SCHEIRER: Open Payments
NPI 1639131337 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,956 in 76 payments from 15 companies in 2025. Trend: 2023 $2,790 · 2024 $2,411 · 2025 $1,956
Food & beverage: $1,956
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $755 |
| Amgen Inc. | 9 | $229 |
| PFIZER INC. | 6 | $228 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Corcept Therapeutics | 2 | $134 |
| Lilly USA, LLC | 5 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $46 |
| Esperion Therapeutics, Inc. | 3 | $45 |
Products named: Wegovy, Ozempic, AIRSUPRA, REPATHA, Korlym, NURTEC ODT, XIFAXAN, Rybelsus.
Industry payments across FL — which companies pay providers there.
